FR3028857B1 - C-GLYCOSIDES DERIVED FROM AMINO ACIDS - Google Patents

C-GLYCOSIDES DERIVED FROM AMINO ACIDS

Info

Publication number
FR3028857B1
FR3028857B1 FR1461526A FR1461526A FR3028857B1 FR 3028857 B1 FR3028857 B1 FR 3028857B1 FR 1461526 A FR1461526 A FR 1461526A FR 1461526 A FR1461526 A FR 1461526A FR 3028857 B1 FR3028857 B1 FR 3028857B1
Authority
FR
France
Prior art keywords
amino acids
monosaccharide
acyclic
polysaccharide
cyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1461526A
Other languages
French (fr)
Other versions
FR3028857A1 (en
Inventor
Maria Dalko
Alexandre Cavezza
Lionel Breton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1461526A priority Critical patent/FR3028857B1/en
Priority to PCT/EP2015/077798 priority patent/WO2016083517A1/en
Publication of FR3028857A1 publication Critical patent/FR3028857A1/en
Application granted granted Critical
Publication of FR3028857B1 publication Critical patent/FR3028857B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • A61Q7/02Preparations for inhibiting or slowing hair growth

Abstract

La présente invention concerne des composés de formule (I) : dans laquelle : Σ représente un monosaccharide ou un polysaccharide comportant de 2 à 20 unités saccharide, ledit monosaccharide ou polysaccharide présentant au moins une fonction hydroxyle libre, et R est un atome d'hydrogène ou un radical alkyle saturé en C1-C6, linéaire ou ramifié, cyclique ou acyclique, ledit radical pouvant être éventuellement (i) substitué par au moins un substituant choisi dans le groupe constitué de =NH, -NH2, -NHR', -NR'2, =O, -OH, -OR', -SH, -SR', -COOR', phényle, phényle substitué par OH ou OR', et des substituants suivants : et/ou (ii) interrompu par un groupe divalent -NH-, -N(COR')- ou -S-, R' désignant un radical alkyle saturé en C1-C6, linéaire ou ramifié, cyclique ou acyclique, ainsi que ses sels, ses stéréoisomères, et ses solvates.The present invention relates to compounds of formula (I): in which: Σ represents a monosaccharide or a polysaccharide comprising from 2 to 20 saccharide units, said monosaccharide or polysaccharide having at least one free hydroxyl function, and R is a hydrogen atom or a saturated, linear or branched, cyclic or acyclic C1-C6 alkyl radical, said radical possibly being (i) substituted by at least one substituent chosen from the group consisting of = NH, -NH2, -NHR ', -NR '2, = O, -OH, -OR', -SH, -SR ', -COOR', phenyl, phenyl substituted with OH or OR ', and the following substituents: and / or (ii) interrupted by a divalent group -NH-, -N (COR ') - or -S-, R' denoting a saturated, linear or branched, cyclic or acyclic C1-C6 alkyl radical, as well as its salts, its stereoisomers and its solvates.

FR1461526A 2014-11-26 2014-11-26 C-GLYCOSIDES DERIVED FROM AMINO ACIDS Active FR3028857B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1461526A FR3028857B1 (en) 2014-11-26 2014-11-26 C-GLYCOSIDES DERIVED FROM AMINO ACIDS
PCT/EP2015/077798 WO2016083517A1 (en) 2014-11-26 2015-11-26 Fluorinated c-glycosides and c-glycosides derived from amino acids as modulators of glut1 and ampk

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1461526A FR3028857B1 (en) 2014-11-26 2014-11-26 C-GLYCOSIDES DERIVED FROM AMINO ACIDS

Publications (2)

Publication Number Publication Date
FR3028857A1 FR3028857A1 (en) 2016-05-27
FR3028857B1 true FR3028857B1 (en) 2017-01-06

Family

ID=52477883

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1461526A Active FR3028857B1 (en) 2014-11-26 2014-11-26 C-GLYCOSIDES DERIVED FROM AMINO ACIDS

Country Status (1)

Country Link
FR (1) FR3028857B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2901135B1 (en) * 2006-05-22 2017-12-08 Oreal USE OF GLYCOLYSIS MODULATORS AS AGENTS REDUCING THE PROLIFERATION OF KERATINOCYTES
FR2939133B1 (en) * 2008-12-03 2011-04-15 Oreal NOVEL AMINO C-XYLOSIDE COMPOUNDS AND USE IN COSMETICS

Also Published As

Publication number Publication date
FR3028857A1 (en) 2016-05-27

Similar Documents

Publication Publication Date Title
MA38540A1 (en) Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists
RU2012117797A (en) HEPARANASE ACTIVITY INHIBITOR
BR112014006482A8 (en) USE OF ISOSORBIDE DERIVATIVES FOR THE PRODUCTION OF COSMETIC PREPARATIONS
NO20084127L (en) Benzylfenylglukopyranosidderivat
MA38583A1 (en) Derivatives of dolastatin 10 and auristatines
AR056502A1 (en) EMPLOYMENT OF LACTATE ESTERS TO IMPROVE THE EFFECT OF PLANT PROTECTIVE AGENTS
BR112013024368A2 (en) active compound combinations
MA38275A1 (en) Saturated and N-acylated nitrogen heterocycles potentiating the activity of an antibiotic active against mycobacteria
MA44021B1 (en) Antitumor compounds
BR112015027164A2 (en) new compounds with triple thrombolysis, antithrombotic and radical neutralization activity, and their synthesis, nanostructure and use
MY197561A (en) Composition for increasing expression of pgc-1?
MX2019006861A (en) Composition based on thiosulfinate and/or thiosulfonate compounds for use in the prevention of bacterial infections in aquatic animals.
BR112017015744A2 (en) compound having a structure of formula (i), a pharmaceutically acceptable salt thereof or an optical isomer thereof, pharmaceutical composition and use of the compound of formula (i) for the treatment and prevention of mycobacterium tuberculosis or other microbial infections
BR112017006798A2 (en) compound, pharmaceutical composition, tnap inhibitor, methods for treating or prophylaxis of a disease or condition and for inhibiting tnap, and use of a compound.
FR3028857B1 (en) C-GLYCOSIDES DERIVED FROM AMINO ACIDS
UA111709C2 (en) APPLICATION OF N-BENZOILSERINE DERIVATIVES TO PREVENT OR WEAK PIGMENTATION
BR112018001816A2 (en) Adamantil Urea Analogs As Soluble Inhibitors Of Epoxide Hydrolase
BR112018015044A2 (en) formulation of personal care, and method of moistening skin or hair in patients
UY28798A1 (en) 5,6-DIALQUIL-7-AMINO-TRIAZOLOPIRIMIDINAS, PROCEDURES FOR THEIR PREPARATION AND THE USE OF THE SAME TO COMBAT HARMFUL FUNGES, AS WELL AS PRODUCTS CONTAINING THEM
EA200970779A1 (en) NEW SULPHATED CONNECTION OF SUGAR AND ITS APPLICATION AS A MEDICINE
BR112015014737A2 (en) spiroisoxazoline compounds having an activity enhancing the activity of an antibiotic
BR102019017344A8 (en) TOPICAL COMPOSITIONS COMPRISING PICHIA ANOMALA AND N-ACETYL GLYCOSAMINE
RU2009138470A (en) COMPOSITION FOR EXTERNAL USE ON SKIN
ECSP23014465A (en) INDOLE ALKALOID WITH FUNGICIDAL EFFECT
FR3075619B1 (en) RESVERATROL XYLOSIDE DERIVATIVES FOR THEIR USE IN COSMETICS

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160527

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9